Latest Breaking News On - Kane biotech - Page 12 : comparemela.com

Kane Biotech Engages Research Capital to Conduct Strategic Review of STEM Animal Health

Kane Biotech Engages Research Capital to Conduct Strategic Review of STEM Animal Health
sina.com.hk - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from sina.com.hk Daily Mail and Mail on Sunday newspapers.

United statesMarc edwardsNicole sendeyRay dupuisVenture exchangeAnimal healthKane biotech incRegulation services providerDechra veterinary productsResearch capital corporation as kaneVeterinary health care councilAnimalcare groupKane biotechResearch capital corporationHealth care councilHonor pet supply company

Kane Biotech Announces Issuance of Restricted Share Units

23.06.2023 - WINNIPEG, Manitoba, June 23, 2023 (GLOBE NEWSWIRE) - Kane Biotech Inc. (TSX-V:KNE; OTCQB:KNBIF), (the “Company” or “Kane Biotech”), today announces that it has issued 9,703,809 restricted share units of the Company (“RSUs”) to various directors, .

Ray dupuisNicole sendeyMarc edwardsVenture exchangeKane biotech incKane biotech

Kane Biotech Announces Issuance of Restricted Share Units

Kane Biotech Announces Issuance of Restricted Share Units
tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.

Nicole sendeyMarc edwardsRay dupuisKane biotech incRegulation services providerVenture exchangeCompany rsusCompany or kane biotechBiotech announces issuanceRestricted shareKane biotechRegarding forward looking

Kane Biotech Announces Issuance of Restricted Share Units

Kane Biotech Announces Issuance of Restricted Share Units
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Marc edwardsNicole sendeyRay dupuisRegulation services providerVenture exchangeCompany rsusCompany or kane biotechKane biotech incKane biotechRegarding forward looking informationthis

Kane Biotech Announces FDA 510(k) Clearance for its coactiv+™ Antimicrobial Wound Gel

Kane’s first FDA cleared medical device aims to disrupt global wound care hydrogel marketWINNIPEG, Manitoba, May 25, 2023 Kane Biotech Inc. announces that on May 24, 2023 it received 510. | May 25, 2023

Costa ricaUnited statesGreg schultzRay dupuisNicole sendeySalud pharmaMarc edwardsProgenacare globalKresser instituteVenture exchangeRegulation services providerDrug administrationCompany or kane biotechEuropean wound management associationKane biotech incAntimicrobial wound gel